Powered by Zembrin®, a patented plant extract derived from controlled cultivation of an elite selection of South African Sceletium tortuosum herb. It increases levels of PDE4 which impacts prefrontal cortex performance PLUS boosts serotonin levels without the adverse withdrawal side effects of conventional medicines (eg. Ritalin). Developed by a team of physicians and neuroscientists, it is backed by scientific and clinical validation: clinical and efficacy studies; in vivo and in vitro safety data; and 300 years of published historic indigenous and colonial plant use. The product has been awarded the first ever Export and Bioprospecting permit by the South African Government in recognition for socially responsible and environmentally sustainable practices.